Research programme: induced pluripotent stem cell derived T cell therapeutics - Help Therapeutics
Alternative Names: iPSC derived T cells - Help TherapeuticsLatest Information Update: 13 Dec 2021
At a glance
- Originator Help Therapeutics
- Class Induced pluripotent stem cell therapies; T lymphocyte cell therapies
- Mechanism of Action T lymphocyte replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Immunological disorders